Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2001;103:469-471

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Domkowski, P. W.
Right arrow Articles by Lowe, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Domkowski, P. W.
Right arrow Articles by Lowe, J. E.
Related Collections
Right arrow Angiogenesis
Right arrow CV surgery: coronary artery disease
Right arrow CV surgery: transplantation, ventricular assistance, cardiomyopathy

(Circulation. 2001;103:469.)
© 2001 American Heart Association, Inc.


Images in Cardiovascular Medicine

Histological Evidence of Angiogenesis 9 Months After Transmyocardial Laser Revascularization

Patrick W. Domkowski, MD, PhD; Shankha S. Biswas, MD; Charles Steenbergen, MD, PhD; James E. Lowe, MD

From the Departments of Surgery and Pathology, Duke University Medical Center, Durham, NC.

Correspondence to James E. Lowe, MD, Professor of Surgery, Department of Surgery, Duke University Medical Center, Box 3954, Durham, NC 27710.

A 66-year-old white male with end-stage ischemic cardiomyopathy was referred to our center for transmyocardial laser revascularization (PLC Eclipse Surgical Technologies) in July 1999. The patient had a long history of interventions for his coronary artery disease, including multiple percutaneous transluminal coronary angioplasties, stent placement in 1991 and 1993, and coronary artery bypass grafting in 1987 and 1992. He was evaluated for a third bypass, but we determined he was not a suitable candidate because of his diffuse small vessel distal coronary artery disease. Given the limitations of conventional therapeutic options, the patient underwent transmyocardial laser revascularization in July 1999. Thirty transmural channels were lased in the ischemic anterior and lateral walls of the left ventricle. The patient tolerated the procedure well and received anginal relief for the following 6 months; he then experienced recurrent symptoms of angina and progressive cardiac failure. Stress thallium201 imaging at that time demonstrated increased ischemic areas in the posterior and inferior myocardium, with improved perfusion in the previously lased anterior and lateral walls. His clinical situation continued to deteriorate, and he was listed for and subsequently received a heart transplant in March 2000. At that time, his native heart was explanted and examined for evidence of angiogenesis in the lased areas of myocardium.

Gross inspection of cross-sections of the explanted heart revealed visible scar tissue in the inferior and posterolateral areas, consistent with old myocardial infarctions; however, no grossly visible scar tissue was evident in the anterolateral lased wall of the left ventricle, either . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
M. B. Leon, R. Kornowski, W. E. Downey, G. Weisz, D. S. Baim, R. O. Bonow, R. C. Hendel, D. J. Cohen, E. Gervino, R. Laham, et al.
A Blinded, Randomized, Placebo-Controlled Trial of Percutaneous Laser Myocardial Revascularization to Improve Angina Symptoms in Patients With Severe Coronary Disease
J. Am. Coll. Cardiol., November 15, 2005; 46(10): 1812 - 1819.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
B. H. Scott, A. J. Ippolito, and I. B. Krukenkamp
Damage to Pulmonary Artery Catheter During Transmyocardial Laser Revascularization
Anesth. Analg., March 1, 2004; 98(3): 614 - 616.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. Saririan and M. J. Eisenberg
Myocardial laser revascularization for the treatment of end-stage coronary artery disease
J. Am. Coll. Cardiol., January 15, 2003; 41(2): 173 - 183.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
R. J. Price and S. Kaul
Contrast Ultrasound Targeted Drug and Gene Delivery: An Update on a New Therapeutic Modality
Journal of Cardiovascular Pharmacology and Therapeutics, September 1, 2002; 7(3): 171 - 180.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. Huikeshoven, J. F. Beek, J. A.P. van der Sloot, R. Tukkie, J. van der Meulen, and M. J.C. van Gemert
35 years of experimental research in transmyocardial revascularization: what have we learned?
Ann. Thorac. Surg., September 1, 2002; 74(3): 956 - 970.
[Abstract] [Full Text] [PDF]